Impact of HIV Infection on Medicare Beneficiaries with Lung Cancer

Table 3

Relative Risk (RR) for all causes mortality and lung cancer mortality.

	Mortality due to any cause		Mortality due to lung cancer
	Relative risk (95% CI)	𝑃 value	Relative risk (95% CI)	𝑃 value
Stage III versus I/II	1.66 (1.64, 1.68)	<0.001	2.11 (2.08, 2.15)	<0.001
Stage IV versus I/II	1.80 (1.78, 1.82)	<0.001	2.40 (2.36, 2.44)	<0.001
Male versus female	1.05 (1.04, 1.05)	<0.001	1.05 (1.04, 1.06)	<0.001
Black versus white	1.02 (1.01, 1.03)	<0.001	0.99 (0.98, 1.01)	0.472
Other versus white	0.96 (0.94, 0.97)	<0.001	0.94 (0.92, 0.96)	<0.001
Age 75–84 versus 65–74	1.04 (1.03, 1.05)	<0.001	1.02 (1.01, 1.03)	<0.001
Age 85+ versus 65–74	1.07 (1.06, 1.08)	<0.001	1.02 (1.01, 1.03)	0.008
Metro versus Big Metro	1.00 (1.00, 1.01)	0.569	1.00 (0.99, 1.01)	0.458
Other versus Big Metro	1.01 (1.00, 1.02)	0.066	1.01 (1.00, 1.02)	0.088
Single versus Other	1.00 (0.99, 1.01)	0.079	0.99 (0.97, 1.01)	0.076
HIV versus non-HIV	0.94 (0.86, 1.02)	0.132	0.84 (0.73, 0.96)	0.011